Disease/Infection News

RSS

Pfizer-BioNTech COVID-19 vaccine may not be associated with adverse effects on fertility and breastfeeding, says study

A recent study by researchers in Singapore shows the absence of evidence for adverse effects on fertility or the presence of the vaccine mRNA (messenger ribonucleic acid) in breast milk, following the administration of the Pfizer BNT162B2 COVID-19 vaccine. This supports efforts to prevent the spread of false information about the effects of the vaccine.

27 May 2021

Norwegian blood samples reveal E. coli variants that are resistant to several antibiotics

One out of ten E. coli samples contained variants that are resistant to several kinds of antibiotics, a new analysis on Norwegian blood samples revealed. The proportion of multi-resistant E. coli bacteria doubled from 2002-2009 to 2010-2017.

27 May 2021

Negative peripartum experiences with the onset of COVID-19: Belgian midwifery case study

It is well known that the onset of the coronavirus disease 2019 (COVID-19) pandemic disrupted most non-essential healthcare services, including antenatal care. A new study from Belgium presents a snapshot of the experiences of midwives in that country during the months of May and June 2020.

27 May 2021

Researchers develop “cell encapsulation” technology to stimulate immunity to fight cancer

Immunotherapy techniques developed in oncology to combat cancerous cells have great potential for fighting viruses.

27 May 2021

Plant-based food can reduce heart disease risk by 10% research shows

In a new study, researchers have found that substituting an animal protein for dinner with a plant protein could reduce the risk of cardiovascular disease by 10%.

27 May 2021

Blood sample analysis can help determine the origin of drugs

The opioid fentanyl is not only used in medical practice as a painkiller, but is also a popular recreational drug. In the United States in particular, fentanyl plays an important role in the opioid crisis that claims many victims every day.

27 May 2021

Could the marine compound plitidepsin promote recovery from moderate COVID-19?

A new paper by an international team of researchers describes experimental evidence of the antiviral efficacy of a marine compound called plitidepsin against SARS-CoV-2. The findings show that plitidepsin inhibits SARS-CoV at low concentrations, as observed by a thousand-fold reduction in genomic RNA and viral titers in cells exposed to the virus in culture when treated.

27 May 2021

Nanobody inhalation found to be effective against COVID-19 in hamsters

In a recent paper, researchers describe an aerosolized nanobody formulation that was found to effectively block SARS-CoV-2 in Syrian hamsters.

27 May 2021

Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO) to Advance Clinical Research of Infectious Diseases

Waters Corporation today introduced a new RUO LC-MS test method to advance critical infectious disease research.

From Waters Corporation 27 May 2021

New DNA COVID-19 vaccine proven effective in mice

A new study has shown that a new DNA-based COVID-19 vaccine successfully induced immunization against SARS-CoV-2 in mice and hamsters.

27 May 2021

OCD linked to higher stroke risk in later life

New findings indicate that the risk of developing ischemic strokes is increased in people with obsessive-compulsive disorder (OCD).

27 May 2021

Study shows CoronaVac to have high seroconversion rate after 40 days

Researchers from the Federal University of Paraná, Brazil, looked into the seroconversion rate after vaccination with the CoronaVac. Using immunoassays, they measured the immunoglobulins (IgG) for anti-nucleocapsid protein (anti-N) antibodies and anti-spike-1 (anti-S1) protein antibodies.

27 May 2021

Online survey provides key insight into the spread of COVID-19 infection

A pilot project using an online survey to gather data on COVID-19 symptoms received more than 87,000 responses from around the world, providing important insight into the spread of disease. Project leaders from Regenstrief Institute, Indiana University and Microsoft believe these questionnaires could be a valuable tool for population health.

27 May 2021

Vagus nerve stimulation may be a potential adjunct therapy for COVID-19

COVID-19 was initially described as lung inflammation, or pneumonia, in older adults. However, we now know that SARS-CoV-2 infections can cause a wide range of symptoms in people of all ages, ranging from no symptoms at all to systemic inflammation and even death.

27 May 2021

Study shows more evidence that vaccines are safe for children, adults

A new study looking across a large body of research finds further evidence for the safety of vaccines that are Food and Drug Administration-approved and routinely recommended for children, adults and pregnant women.

27 May 2021

New plasmofluidic chip could speed up diagnosis during current and future pandemics

Reverse transcription-polymerase chain reaction (RT-PCR) has been the gold standard for diagnosis during the COVID-19 pandemic.

27 May 2021

Protein-RNA interactions in SARS-CoV-2-infected cells reveal key regulators of infection

Researchers in the UK, including the University of Oxford and Glasgow, as well as the University of Heidelberg, published their analysis of protein-RNA interactions in SARS-CoV-2 and the subsequent significance in the journal Molecular Cell. This research could help to uncover novel antiviral strategies for COVID-19 due to a broader understanding of how the virus works.

27 May 2021

House design can decrease the force of malaria infection

There is growing evidence that house design can decrease the force of malaria infection. The world's most deadly assassin is Africa's malaria mosquito: Anopheles gambiae.

27 May 2021

Diet quality and food security are affected by home food procurement during COVID-19

Home food procurement (HFP), including fishing, gardening, hunting, foraging, backyard livestock, and canning, have been important ways for people to obtain food historically. Research shows that some HFP activities such as gardening have recently increased, while others such as hunting have decreased in the US.

27 May 2021

Strict social distancing, non-pharmaceutical methods are still needed to end second wave of COVID-19

Current vaccination programmes alone will have a limited effect in stopping the second wave of COVID infections in the US, according to a study conducted by scientists from Reykjavik University, University of Lyon, University of Southern Denmark and University of Naples Federico II, and published in the Nature Group journal Scientific Reports today.

27 May 2021

Disease/Infection News

Pfizer-BioNTech COVID-19 vaccine may not be associated with adverse effects on fertility and breastfeeding, says study

Norwegian blood samples reveal E. coli variants that are resistant to several antibiotics

Negative peripartum experiences with the onset of COVID-19: Belgian midwifery case study

Researchers develop “cell encapsulation” technology to stimulate immunity to fight cancer

Plant-based food can reduce heart disease risk by 10% research shows

Blood sample analysis can help determine the origin of drugs

Could the marine compound plitidepsin promote recovery from moderate COVID-19?

Nanobody inhalation found to be effective against COVID-19 in hamsters

Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO) to Advance Clinical Research of Infectious Diseases

New DNA COVID-19 vaccine proven effective in mice

OCD linked to higher stroke risk in later life

Study shows CoronaVac to have high seroconversion rate after 40 days

Online survey provides key insight into the spread of COVID-19 infection

Vagus nerve stimulation may be a potential adjunct therapy for COVID-19

Study shows more evidence that vaccines are safe for children, adults

New plasmofluidic chip could speed up diagnosis during current and future pandemics

Protein-RNA interactions in SARS-CoV-2-infected cells reveal key regulators of infection

House design can decrease the force of malaria infection

Diet quality and food security are affected by home food procurement during COVID-19

Strict social distancing, non-pharmaceutical methods are still needed to end second wave of COVID-19

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News